News & Stories
Researchers Find Source of Breast Tumor Heterogeneity and Pathway that Limits Emergence
Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
Genetic Testing for Breast Cancer
Family history remains on the National Cancer Institute’s list of risk factors for breast cancer, but what does it mean when cancer “runs in the family?"
Norris Cotton Cancer Center Launches New Cellular Therapy Program
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch and the Supercharged, Cancer-Killing CAR T-Cells
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Clinical Trial of Anti-VISTA Cancer Antibody Therapy Opens for Patient Enrollment
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.
Norris Cotton Cancer Center Receives National Award for Patient Experience
This Press Ganey award recognizes institutions who have maintained consistently high levels of excellence in patient experience over a three-year period.
Alumni Gifts will Accelerate Innovations in Cancer Prevention and Treatment
Five Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer.